New: NCI-funded clinical trial search
Mednet Logo
CommunityEndocrinology

Endocrinology

Physician discussions on diabetes management, thyroid disorders, hormonal imbalances, and metabolic conditions.

Recent Discussions

Is there any benefit to trend testosterone and DHEA-S levels in patients with PCOS to determine response to therapy?

1
1 Answers

Mednet MemberInvited Expert
Endocrinology · Brigham And Womens Hospital Endocrinology

A recent guideline for the diagnosis and management of PCOS in patients states: “Repeated androgen measures for the ongoing assessment of PCOS in adults have a limited role” (International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023). That said, I thi...

Do you offer semaglutide for weight loss management in patients with CKD?

2
2 Answers

Mednet Member
Nephrology · Southern Utah Kidney And Hypertension Center

I do, but mostly a different GLP-1, trizipitide. I think the side effect profile is cleaner and better tolerated in CKD and post-transplant patients, decreasing renal complications associated with the side effects.

Do you still consider changing atypical antipsychotics that are working well in children undergoing puberty if the prolactin levels are high but there are no symptoms of drug-induced hyperprolactinemia?

5
4 Answers

Mednet Member
Psychiatry · Windmoor Healthcare Of Clearwater

I consider the risk of osteoporosis if I believe it may be used long-term, even if asymptomatic. Typically, I warn parents of the risk but continue the medication if the prolactin is only mildly elevated. I find it rare to find an adult patient who is taking the same drugs they did in adolescence. L...

About Mednet

A community where doctors find answers to medicine's toughest questions.

  • Verified, credentialed physicians
  • 45,000+ members across 24 specialties
  • Free CME and MOC credit

How do you manage orthostatic symptoms from autonomic neuropathy due to diabetes?

1
2 Answers

Mednet MemberInvited Expert
Neurology · University of Kansas Medical Center

Try conservative measures such as hydration, pressure stockings, abdominal binder, exercises, and precautions prior to positional change. Addition of midodrine or other medications like flourinef and adjustment of doses of their antihypertensive medications. There are other medications that can be u...

When discontinuing Denosumab after more than 2-3 years of therapy, when do you recommend giving the first dose of zoledronic acid?

1
3 Answers

Mednet MemberInvited Expert
Endocrinology · Duke University Hospital

My practice has been that after 2-3 years of denosumab, I wait 6 months and then start zoledronic acid.

What hormonal workup is recommended for a male with abnormally high serum testosterone not on supplements or hormone replacement therapy?

1
1 Answers

Mednet MemberInvited Expert
Endocrinology · Endocrine Care Center At Uw Medical Center Roosevelt

First, one has to make a distinction between a high serum total testosterone and a high serum free testosterone concentrations measured by an accurate methodology. A high total serum testosterone with a normal serum free testosterone occurs with patients with high concentrations of proteins that bin...

What therapies do you offer to patients with hypophosphatasia and low bone density who do not qualify for enzyme replacement therapy?

1 Answers

Mednet MemberInvited Expert
Endocrinology · Boston University School of Medicine

I have seen several patients like this. I recommend vitamin D to maintain 25-hydroxyvitamin D of 40-60 ng/mL, which usually requires 3000-5000 IUs daily. A good source of dietary calcium; my preference is 1000 mg from dairy sources, which not only provides a good source of bioavailable calcium but a...

Do you consider adding a GLP-1 receptor agonist to insulin therapy in a patient with newly diagnosed LADA who has not yet progressed to insulin dependence?

2 Answers

Mednet MemberInvited Expert
Endocrinology · Brigham And Womens Hospital Endocrinology

Auto-immune diabetes is known to have identifiable stages of beta-cell dysfunction and demise and being able to intervene with a treatment to preserve or improve beta-cell function is one of the major areas of diabetes research. Latent auto-immune diabetes presenting in adults (LADA) at a time when ...

How long after a DKA episode do you anticipate patients with ketosis prone diabetes mellitus to be able to discontinue insulin therapy?

2 Answers

Mednet MemberInvited Expert
Endocrinology · Emory University School of Medicine

If the patient is antibody negative with beta cell function, they can usually discontinue insulin 1 to 2 months after the initial diabetic ketoacidosis (DKA) event (I typically order the antibodies and C-peptide at their first follow-up visit and then will start to pull off insulin once I have the r...

For a patient with a large pheochromocytoma, how would you evaluate for possible autonomous cortisol co-secretion prior to adrenalectomy to assess need for risk of glucocorticoid withdrawal postoperatively?

1 Answers

Mednet MemberInvited Expert
Endocrinology · Washington University School of Medicine

From a practical standpoint, and given that this is rare, it is reasonable to check a postoperative day 1 (POD1) AM cortisol and decide then whether cortisol replacement is needed. You can also check ACTH, AM and PM cortisol to assess diurnal variation, and DHEAS pre-op to get some idea.